CS Capital
Beijingpwc.com
Overview
CS Capital is a China-based private equity investment firm that focuses on growth equity investments in sectors including smart electric vehicles, life sciences, and digitalization.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Stegra | Jan 2024 | Debt | Co-investor |
| Lai Kai Pharmaceutical Technology | Jun 2023 | IPO | Co-investor |
| Hithium | Jun 2023 | Series C | Co-investor |
| Lai Kai Pharmaceutical Technology | May 2022 | Series D | Lead |
| InxMed Limited | Mar 2022 | Series B | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
